PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,150,000 | -52.3% | 25,081 | -38.5% | 0.51% | -51.1% |
| Q2 2018 | $2,413,000 | +43.5% | 40,788 | +65.1% | 1.05% | +66.6% |
| Q1 2018 | $1,681,000 | -43.1% | 24,700 | -17.4% | 0.63% | -30.5% |
| Q4 2017 | $2,956,000 | +15.3% | 29,900 | +39.7% | 0.90% | +16.3% |
| Q3 2017 | $2,563,000 | +51.9% | 21,400 | +10.9% | 0.78% | +62.9% |
| Q2 2017 | $1,687,000 | +53.2% | 19,300 | -34.8% | 0.48% | +34.7% |
| Q1 2017 | $1,101,000 | +154.9% | 29,600 | +700.0% | 0.35% | +178.7% |
| Q2 2015 | $432,000 | -20.4% | 3,700 | +60.9% | 0.13% | -29.1% |
| Q1 2015 | $543,000 | -1.1% | 2,300 | -20.7% | 0.18% | -16.7% |
| Q4 2014 | $549,000 | – | 2,900 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |